• About Gilead
    • Corporate Overview
    • Leadership
    • Worldwide Operations
    • Policy Perspectives
    • Business Conduct
    • Ethics
    • Partners and Business Development
  • Products
    • Request Information
    • Consumer Product Safety
      Improvement Act
    • Product Approvals Timeline
  • Research
    • Pipeline
    • Clinical Trials
    • Investigator-Sponsored Research (ISR)
  • Investors
    • Corporate Governance
    • Stock Information
    • Financial Information
    • News and Events
    • Email Alerts
    • Financial FAQ
    • Contact Information
  • Newsroom
    • Press Releases
    • Media Inquiries
    • Policy Perspectives
    • Media FAQ
  • Community
  • Careers
    • Current Opportunities
    • Culture
    • U.S. Benefits
   CONTACT    SITE MAP  
   SEARCH
Gilead
 
U.S. Patient Access
  • U.S. Patient Access
    U.S. Advancing Access® Atripla® Patient Assistance Program Gilead™Solutions Cayston® Access Program Ranexa Connect™
  • Developing World Access
  • Corporate Grants and Giving

Gilead supports a number of programs for eligible patients in the United States who do not have insurance, are underinsured or who otherwise need financial assistance. These programs include:

  • U.S. Advancing Access®
  • Atripla® Patient Access Program
  • Gilead™Solutions
  • Cayston® Access Program
  • Ranexa Connect™
© 2012 Gilead | Terms of Use | Privacy